The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Phytoestrogen-Induced Phosphorylation of MAP Kinase in Osteoblasts is Mediated by Membrane Estrogen Receptor

  • Park, Youn-Hee (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Park, Hwan-Ki (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Lee, Hyo-Jin (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Park, Sun-Mu (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Choi, Sang-Won (Department of Food Science and Nutrition, Catholic University of Daegu) ;
  • Lee, Won-Jung (Department of Physiology, School of Medicine, Kyungpook National University)
  • Published : 2002.06.21
Download PDF
⟨ Previous Next ⟩

Abstract

We have previously demonstrated that phytoestrogens isolated from safflower seeds significantly attenuated bone loss in ovariectomized rats, and directly stimulated proliferation and differentiation of cultured osteoblastic cells. In an attempt to elucidate underlying cellular mechanisms, in the present study we investigated effects of $17{\beta}-estradiol\;(E_2)$ and phytoestrogens such as matairesinol and acacetin, a type of lignan and flavonoid, respectively, on activation of mitogen activated protein (MAP) kinases, extracellular signal-regulated kinase 1 (ERK1) and ERK2, in cultured osteoblastic ROS 17/2.8 cells. Western blot analysis with anti-MAP kinase antibody showed that a wide range concentrations $(10^{-14}\;to\;10^{-6}\;M)\;of\;E_2$ as well as both phytoestrogens induced rapid and transient activation of ERK1/2 through phosphorylation within minutes. Maximum activation of MAP kinases by $E_2$ and phytoestrogens were observed at 10 and 15 min, respectively. $E_2-induced$ phosphorylation of ERK1/2 returned to the control level at 30 min, whereas phytoestrogen-induced phosphorylation was maintained at high level until 30 min. PD-98059, a highly selective inhibitor of MAP kinase, prevented phosphorylation of ERK1/2 in the cells treated either with $E_2$ or phytoestrogens. To examine a possible involvement of estrogen receptor in the activation process of MAP kinase, Western blot analysis was performed in the presence and absence of the estrogen receptor antagonists, ICI 182,780 and tamoxifen. These antagonists blocked MAP kinase phosphorylation induced not only by $E_2,$ but also by the phytoestrogens. To the best our knowledge, this study is the first to demonstrate that phytoestrogens such as flavonoid and lignan extracted from safflower seeds produce a rapid activation of MAP kinase, at least partially via membrane estrogen receptor of the cultured osteoblastic cells.

Keywords

References

  1. Adams NR, et al. Phytoestrogens. In: Cheeke P ed, Toxicants of plant origin, CRC Press, Boca Raton, FL., p23－51, 1989
  2. Axelson M, Sjovall J, Gustafsson BE, Setchell KD. Origin of lignans in mammals and identification of a precursor from plants. Nature 298: 659－660, 1982 https://doi.org/10.1038/298659a0
  3. Brzezinski A, Debi A. Phytoestrogens: the natural selective estrogen receptor modulators? Eur J Ob/Gy Reprod Biol 85: 47－51, 1999 https://doi.org/10.1016/S0301-2115(98)00281-4
  4. Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul 2: 965－978, 1991
  5. Collins P, Webb C. Estrogen hits the surface. Nature 5: 1130－1131, 1999 https://doi.org/10.1038/13453
  6. Dongeuibokam (東醫寶鑑). Yeokang Publisher, Seoul, p27－63, 1989
  7. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 127: 1795－1799, 1997
  8. Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94: 739－743, 1994 https://doi.org/10.1016/0002-8223(94)91939-9
  9. Endoh H, Sasaki H, Maruyama K, Takeyama K, Wage I, Shimizu T, Kato S, Kawashima H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235: 99－102, 1997 https://doi.org/10.1006/bbrc.1997.6746
  10. Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842－1846, 1989 https://doi.org/10.1016/S0002-9378(89)80004-3
  11. Goetz RM. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96: 2788－2793, 1999 https://doi.org/10.1073/pnas.96.6.2788
  12. Ibrahim NK, Hortobagyi GN. The evolving role of specific estrogen receptor modulators (SERMs). Surgical Oncology 8: 103－123, 1999 https://doi.org/10.1016/S0960-7404(99)00047-X
  13. Kang GH, Chang EJ, Choi SW. Antioxidative activity of phenolic compounds in roasted safflower (Carthamus tinctorius L.) seeds. J Food Sci Nutr 4: 221－225, 1999
  14. Kim HJ. Polyphenols extracted from safflower seeds stimulate the proliferation and differentiation of osteoblastic cells. MS thesis. Kyungpook National University, 2001
  15. Kim HJ. Park RW, Bae YC, Choi SW, Cho SH, Choi YS, Lee WJ. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tis Int, 2002 (in press)
  16. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR. Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241: 81－84, 1988 https://doi.org/10.1126/science.3164526
  17. Kurzer M, Xu X. Dietary phytoestrogens. Annu Rev Nutr 17: 353－ 381, 1997 https://doi.org/10.1146/annurev.nutr.17.1.353
  18. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. ERK is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276: 14443－14450, 2001
  19. Lieberherr M, Grosse B, Kachkache M, Balsan S. Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8: 1365－1376, 1993 https://doi.org/10.1002/jbmr.5650081111
  20. Michaelsson K, Baron JA, Farahmand BY, Johnell O, Magnesson C, Persson PG, Persson I, Ljunghall S. Hormone replacement therapy and risk of hip fracture: population based case-control study. The swedish hip fracture study group. Br Med J 316: 1858－ 1863, 1998 https://doi.org/10.1136/bmj.316.7148.1858
  21. Migliaccio A, Di DM, Castoria G. Tyrosine kinase/p21ras/MAP kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292－1300, 1996
  22. Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed rcombinant human estrogen receptor. J Steroid Biochem Molec Biol 49: 153－160, 1994 https://doi.org/10.1016/0960-0760(94)90005-1
  23. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10: 253－ 260, 1999. https://doi.org/10.1023/A:1008909128110
  24. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptor (ERs) originate from a single transcript: studies of ER alpha and ER beta expressed in Chinese hamster ovary cells. Mol Endocrinol 13: 307－319, 1999 https://doi.org/10.1210/me.13.2.307
  25. Setchell KDR, Adlercreutz H. Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: The role of gut microflora in toxicity and cancer. Academic Press, London, p 315－345, 1988